Aberrant induction of p19Arf-mediated cellular senescence contributes to neurodevelopmental defects
Valproic acid (VPA) is a widely prescribed drug to treat epilepsy, bipolar disorder, and migraine. If taken during pregnancy, however, exposure to the developing embryo can cause birth defects, cognitive impairment, and autism spectrum disorder. How VPA causes these developmental defects remains unk...
Main Authors: | Muriel Rhinn, Irene Zapata-Bodalo, Annabelle Klein, Jean-Luc Plassat, Tania Knauer-Meyer, William M. Keyes |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-06-01
|
Series: | PLoS Biology |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197032/?tool=EBI |
Similar Items
-
Aberrant induction of p19Arf-mediated cellular senescence contributes to neurodevelopmental defects.
by: Muriel Rhinn, et al.
Published: (2022-06-01) -
ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling
by: Maximilian Hirschenberger, et al.
Published: (2023-11-01) -
Epigenetic regulation of p16Ink4a and Arf by JDP2 in cellular senescence
by: Nakade Koji, et al.
Published: (2010-05-01) -
Sesamin Metabolites Suppress the Induction of Cellular Senescence
by: Chie Araki, et al.
Published: (2023-03-01) -
Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
by: Petra Koudelkova, et al.
Published: (2015-01-01)